Speeding Up Drug Development In The Cloud.
This article brings us a step forward in sharing information pertinent to urgent drug development via cloud computing among researchers and those involved its process. It takes an average of 12 years for a drug to travel from the research lab to the patient. In addition, only five in 5,000, or 10%, of the drugs that begin preclinical testing ever make it to human testing. Only one of these five is ever approved for human usage. On average, it will cost a company $359 million to develop a new drug from the research lab to the patient. Various scientists and researchers are involved in the development of a new drug, including organic chemists, scientists, physiologists, and statisticians. In more recent years, they have been joined by specialists: like biochemists, who study the chemistry of life processes; molecular biologists, who study the molecules that make up living matter; toxicologists, who investigate chemicals’ potential for harm; pharmacologists, who look at how drugs work; and computer scientists, who apply the power of their sophisticated machines to analyse and assess new chemicals. The new drug development and approval process may be one of the most difficult processes in the world. In the USA, the Food and Drug Administration (FDA) monitors and regulates the new drug development process. The FDA plays a much more crucial role during the various clinical trial phases. If the drug shows successful effects in humans and the FDA approves it to be prescribed by physicians to humans, the FDA will determine what information should be placed on the label including, directions for use, potential side effects, and other necessary warnings. With cloud computing, all these professionals have similar access to available pertinent information, both intra-professional and inter-professional, to aid them in their pursuit of urgent drug development.
Read Article Here: